Log in with your email address username.


Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Correspondence] New ACMD regulations threaten UK’s pharmaceutical discovery

In December, 2016, the UK Government, on the advice of the Advisory Council on the Misuse of Drugs (ACMD), made two problematic changes to the UK drug control regulations of the Misuse of Drugs Act 1971. First, they put into effect new very wide-ranging bans against a whole range of synthetic cannabinoids. Second, they rejected an appeal by senior UK scientists to remove tetrahydrocannabivarin (THCV) from Schedule 1—the highest level of control—of the Act. THCV is a chemical found in the cannabis plant that UK scientists have identified as a potential therapeutic: keeping it in Schedule 1 severely impedes their research of THCV in the UK.